Edition:
United Kingdom

Proteon Therapeutics Inc (PRTO.OQ)

PRTO.OQ on NASDAQ Stock Exchange Global Market

1.89USD
22 Oct 2018
Change (% chg)

$-0.08 (-4.06%)
Prev Close
$1.97
Open
$1.97
Day's High
$2.07
Day's Low
$1.89
Volume
1,888
Avg. Vol
8,603
52-wk High
$2.90
52-wk Low
$1.50

Chart for

About

Proteon Therapeutics, Inc. is a late-stage biopharmaceutical company, which focuses on the development of pharmaceuticals to address the needs of patients with renal and vascular disease. The Company is involved in research and development activities. The Company's product candidate, product candidate, vonapanitase, formerly... (more)

Overall

Beta: --
Market Cap(Mil.): $46.69
Shares Outstanding(Mil.): 17.62
Dividend: --
Yield (%): --

Financials

  PRTO.OQ Industry Sector
P/E (TTM): -- 85.41 33.64
EPS (TTM): -1.56 -- --
ROI: -65.10 0.21 14.27
ROE: -65.10 1.17 15.99

BRIEF-Proteon Therapeutics Announces Qtrly Loss Per Share $0.34

* PROTEON THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

09 May 2018

BRIEF-Proteon Therapeutics And Lonza Extend Manufacturing Agreement For Commercial Supply

* PROTEON THERAPEUTICS AND LONZA EXTEND MANUFACTURING AGREEMENT FOR COMMERCIAL SUPPLY

08 May 2018

Earnings vs. Estimates